Gallo Michele, Demertzis Stefanos, Gerosa Gino, Ferrari Enrico
Cardiac Surgery Unit, Cardiocentro Ticino Foundation, Lugano, Switzerland.
Cardiac Surgery Unit, Department of Cardiac, Thoracic and Vascular Sciences, University Hospital of Padova, Italy.
J Heart Valve Dis. 2017 Jan;26(1):9-11.
Transcatheter heart valve replacement is an emerging technology in the treatment of valvular disease. During recent years, the opportunity to replace a heart valve via percutaneous access or via a miniinvasive access without the use of cardiopulmonary bypass has revolutionized the approach to this pathology. The different designs of transcatheter valves have also altered the spectrum of possible complications, with the unexpected occurrence of leaflet hypomobility after valve deployment. Here, the pathophysiological pattern of this complication is categorized, and an analysis provided of recently reported clinical evidences.
经导管心脏瓣膜置换术是治疗瓣膜疾病的一项新兴技术。近年来，通过经皮途径或微创途径在不使用体外循环的情况下置换心脏瓣膜的机会彻底改变了对这种病症的治疗方法。经导管瓣膜的不同设计也改变了可能出现的并发症范围，出现了瓣膜植入后瓣叶活动度降低这一意外情况。在此，对该并发症的病理生理模式进行了分类，并对最近报道的临床证据进行了分析。
